Printed from Voxsanity (voxsanity.com.au) — NCT06605404 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.
Back to Pancreatic Cancer
Pancreatic Cancer Trial, Recruiting
NCT06605404
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 years or older.
- People with a confirmed solid tumour diagnosis (proven by biopsy or lab testing) that fits into one of the trial's specific cancer groups or the general "Mix of Solid Tumors" group.
- People whose cancer is being treated with the aim of a cure, with surgery to remove the cancer either planned or already completed within the last 3 months, and before any additional post-surgery treatment has started.
- People with a general health and activity level rated as fully active, mildly limited, or moderately limited (confirmed with trial site).
- People who have not received any systemic (whole-body) cancer treatment for their current cancer before joining the trial.
- People who are willing and able to follow all study procedures, including providing blood samples and tumour tissue from a biopsy or surgery.
- People who had a previous invasive cancer (other than certain common skin cancers or blood cancers) only if all treatment for that cancer, including hormone therapy, was fully completed 3 or more years ago.
- People with a history of a non-invasive (in situ) cancer who have received definitive treatment for it, with no waiting period required.
- People who do not currently have another active invasive cancer (common non-melanoma skin cancers are an exception).
- People who have never had a stem cell transplant using donor cells from another person.
- People who are able and willing to sign a consent form and allow their personal health information to be used for the study.
- For the bladder cancer and melanoma groups: people with Stage II or operable Stage III cancer.
- For the oesophageal, stomach/gastroesophageal junction, and non-small cell lung cancer groups: people with Stage I, II, or operable Stage III cancer.
- For the pancreatic cancer group: people with Stage I, II, or operable Stage III cancer affecting the exocrine part of the pancreas only.
- For the general "Mix of Solid Tumors" group: people with a Stage II or operable Stage III solid tumour that is not covered by any of the other specific groups.
Who may not be able to join:
- People whose cancer is in the brain or central nervous system.
- People with colorectal (bowel) cancer.
- People with breast cancer.
- People with squamous cell skin cancer or basal cell skin cancer.
- People with gastrointestinal stromal tumours (GIST).
- People with thyroid cancer.
- People with uveal melanoma (a type of eye cancer).
- People with low or intermediate grade neuroendocrine tumours (note: high-grade neuroendocrine tumours, Merkel cell carcinoma, and small cell lung cancer are permitted — confirm with trial site).
- People with blood cancers, including multiple myeloma, Hodgkin's lymphoma, non-Hodgkin's lymphoma, or any form of leukaemia.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
Contact this trial
Phone: 888-662-6367
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Status
Recruiting
Phase
Not Applicable
Sponsor
Paradigm Health
Registry
ClinicalTrials.gov
Start date
8 January 2025
Est. completion
1 December 2031
Where this trial is recruiting
🇺🇸 United States
Primary endpoints
Blood and tissue biospecimen registry
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.
Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.